GET DAILY SIGNALSEMR's +22% Run vs CMI's Recent Dip: Weighing Two Industrial Leaders
Key Takeaways
- Emerson Electric Co. (EMR) has posted stronger recent relative performance, with shares up roughly 22% over the past 52 weeks, while Cummins Inc. (CMI) has pulled back near its 52-week low after trimming its full-year outlook.
- Cummins (CMI) delivered record quarterly EBITDA, yet weakness in North American pickup truck demand weighed on guidance and triggered several analyst price-target cuts.
- Emerson (EMR) reported its strongest order growth in years, driven by software and systems, LNG, power, and aerospace and defense demand.
- Tickeron AI Verdict: EMR is the ticker of choice in this comparison, reflecting its more consistent uptrend, accelerating order momentum, and improving analyst sentiment relative to CMI.
- For deeper context, explore CMI Major News and CMI Today's Price Move, as well as EMR Major News and EMR Today's Price Move.
- To see how automated strategies are positioning across these and thousands of other tickers, explore Trending AI Robots.
Why This Comparison Matters
This stock comparison examines two industrial heavyweights operating at different points in the energy and automation landscape. Cummins Inc. (CMI) is a global leader in engines and power generation, while Emerson Electric Co. (EMR) is an industrial technology and software company focused on automation. Both firms are leveraged to the electrification and data-center themes, yet their recent market positioning has diverged. This comparison is relevant for investors weighing cyclical engine demand against higher-margin automation software, and for traders assessing which name currently offers more consistent trend strength and momentum in the broader industrial sector. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.
Cummins' Recent Results and Challenges
Cummins Inc. (CMI) designs and manufactures diesel and natural gas engines, power generation systems, and powertrain components, serving commercial trucks, construction, mining, and data-center backup power markets. In recent weeks, the company reported strong third-quarter results with revenue up 13% year over year and record EBITDA, led by its Power Systems segment, which reached record sales on robust data-center demand.
Despite this operating strength, sentiment has been pressured by softer North American pickup truck demand, which led management to narrow its full-year revenue growth guidance to approximately 10%, from a prior 10%–13% range. The stock has pulled back toward the lower end of its 52-week range in recent market activity, and several analysts lowered price targets following the results even as others maintained Buy ratings. This mixed reaction highlights a contrast between durable power-generation demand and cyclical weakness in consumer-facing truck markets.
Emerson's Momentum and Outlook
Emerson Electric Co. (EMR) is a global automation leader spanning control systems, measurement instrumentation, and industrial software. In its most recent quarterly report, Emerson posted underlying sales growth of 7% and, more notably, underlying order growth of 14% — its strongest in several years — supported by software and systems, LNG, power, and aerospace and defense end markets. Backlog rose 11% year over year.
Shares have outperformed the broader market over the past 52 weeks, climbing more than 20% and recently trading near multi-year highs. The company also raised its dividend and announced plans to return roughly $3.8 billion to shareholders in fiscal 2027. A wave of analyst price-target increases followed the results, reflecting confidence in order momentum and margin expansion, though the stock's elevated valuation remains a point of debate among some firms. From what I see, the order acceleration stands out as a key positive signal.
Head-to-Head: Business Models and Drivers
The two companies differ sharply in business model and market positioning. Cummins (CMI) is anchored in cyclical engine and power hardware, with a substantial distribution footprint and heavy exposure to North American truck and industrial demand. Emerson (EMR) skews toward automation software and high-margin instrumentation, with a larger recurring-revenue and project-based profile tied to energy security, electrification, and nearshoring.
Growth drivers also diverge: Cummins' near-term momentum leans on data-center power generation, while pickup truck softness creates a headwind. Emerson's momentum is broader, spanning LNG, power, life sciences, and semiconductor markets. On risk factors, Cummins faces cyclical demand sensitivity and ongoing regulatory transition in emissions standards, whereas Emerson faces valuation risk after its strong run and some debate over competitive pressures in automation. In terms of recent market sentiment, Emerson has enjoyed consistent upward price-target revisions, while Cummins has seen a more mixed analyst response, underscoring a trade-off between cyclical value and higher-growth, higher-multiple positioning.
Tickeron AI Verdict
Based on observable trend consistency, order momentum, and relative market positioning, Tickeron's AI would currently favor EMR over CMI. Emerson's shares have demonstrated a more stable uptrend and recently reached multi-year highs, supported by accelerating order growth and improving analyst sentiment. Cummins, while generating record profitability and benefiting from robust power-generation demand, has experienced a choppier trend as guidance was trimmed and its stock approached the lower end of its range. The AI verdict reflects these observable differences in momentum and stability rather than a definitive prediction, and it should be understood as a probabilistic read of current conditions, not personal investment advice. I'm watching this closely for any shifts in order trends or guidance updates.
Exploring Automated Trading Strategies
In my own research process, I often review Tickeron’s Trending AI Robots to understand how different automated strategies are positioned across industrials and other sectors. The platform hosts hundreds of AI trading bots with varied styles, timeframes, and performance histories, helping surface data-driven approaches suited to current market conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for EMR turns positive, indicating new upward trend
EMR saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 60 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 66%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 219 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 151 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 19 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 34 of 60 cases where EMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 57%.
The Moving Average Convergence Divergence Histogram (MACD) for EMR turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 27 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.444) is normal, around the industry mean (3.805). P/E Ratio (35.370) is within average values for comparable stocks, (36.482). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.014) settles around the average of (0.032) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of process controls systems, valves and analytical instruments
Industry IndustrialMachinery
Advertisement